We are driving innovation with industry and manufacturing partners to transform industries and deliver growth to our economies, thereby helping to improve people’s livelihoods.
We are improving the health of people across the world through new discoveries, treatments and patient pathways and working in partnership to build a transformative health ecosystem in our region.
We are working to understand the impact of climate change on the planet and its people, to improve air quality, and developing new technologies to decarbonise energy and transport in partnership with industry and government.
We are working with our partners to tackle inequalities in all aspects of society, striving to make change for a fairer world and one in which people can enjoy a fulfilling, rewarding life.
We explore what it means to be human – in historical and cultural contexts, within ethical and legal norms and through languages and communication.
From atoms to astronomy, computers to cars and robots to robust materials, our goal is to transform our understanding of the world to make life easier, healthier and more sustainable.
Across the breadth of life and environmental sciences, we discover, apply and translate science to forge major advances in human and environmental health.
With more than 1,000 academic staff researchers and around £80 million new research funding per year, we are dedicated to performing world-leading research with the ultimate goal of improving human health.
We address the challenges facing society and the economy, from shedding light on the refugee crisis, to character education in schools, through to developing leaders in the NHS.
Cancer Research UK Clinical Trials Unit (CRCTU) has a presence in nearly 400 sites in over 20 countries delivering its vision for innovative and efficient trials to meet the needs of patients in the modern era of multi-modality and multiomic therapeutics.
Our full portfolio of trials.
CRCTU welcomes applications to collaborate with us.
Our new Clinical Trials MSc covers the theoretical and practical aspects of the design, conduct, analysis and interpretation of clinical trials.
12 June 2017
Researchers at the University of Birmingham have found that a type of protein could hold the secret to suppressing the growth of breast cancer tumours.
07 June 2017
One of the largest clinical trials for prostate cancer led by the University of Birmingham has found that adding Abiraterone to hormone therapy at the start of treatment improves survival by 37%.
25 May 2017
A study led by the University of Birmingham has made a breakthrough in the understanding of how different genetic mutations cause acute myeloid leukaemia.
13 April 2017
The Cancer Research UK Birmingham Centre, will bring together researchers specialising in understanding cancer genetics, how cancer avoids our body's defences and the role viruses play in certain cancers.
A new study has identified novel mechanisms whereby T cells may be able to distinguish an emerging class of targets specifically increased on cancer cells.
18 October 2016
The University of Birmingham's iconic clock tower 'Old Joe' turns pink this evening to mark the start of Breast Cancer Now's annual awareness month.
11 October 2016
Scientists at the University of Birmingham have described a previously-unknown molecular mechanism that could lead to the genetic mutations seen in certain types of aggressive cancer cells.
07 October 2016
A team of six scientists from the University of Birmingham will swap their lab coats for running vests as they take on the Great Birmingham Run on Sunday 16 October to raise money for the blood cancer charity Bloodwise.
21 September 2016
A new analytical test has been launched in the UK that provides sensitive, specific and efficient predictive analysis of a rare form of cancer from a simple urine sample.
16 September 2016
Experts from the University of Birmingham today joined Indian partners to lay the foundations for a new study into women's cancers that could help to diagnose, treat and prevent the disease.
11 July 2016
Researchers from the University of Birmingham and hospitals across the West Midlands have revealed how a common symptomless condition can develop into the blood cancer myeloma.
27 May 2016
The University of Birmingham's Cancer Research UK Clinical Trials Unit will coordinate the UK arm of a large international clinical trial for a type of children's brain tumour, called ependymoma.
View all news